Works by Fang, Zujun


Results: 18
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Hengli<sup>®</sup> Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.

    Published in:
    Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.840695
    By:
    • Liao, Limin;
    • Liu, Qinggang;
    • Cong, Huiling;
    • Xu, Zhihui;
    • Li, Enhui;
    • Weng, Zhiliang;
    • Jiang, Haihong;
    • Liu, Ben;
    • Huang, Xiao;
    • Xia, Shujie;
    • Wen, Wei;
    • Wu, Juan;
    • Shi, Guowei;
    • Wang, Yang;
    • Li, Peijun;
    • Yu, Yang;
    • Fang, Zujun;
    • Zheng, Jie;
    • Tian, Ye;
    • Shang, Donghao
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18